 |
double stranded RNA which targets the mutated KRAS oncogene |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-01-26 00:00:00 |
| Sponsor | Silenseed Ltd;Goldyne Savad Institute of Gene Therapy, Jerusalem, 9112001; |
